Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study

doi:10.1016/S0140-6736(02)07953-9

The Lancet

Volume 359, Issue 9309, 9 March 2002, Pages 831-834

https://doi.org/10.1016/S0140-6736(02)07953-9 Get rights and content

Summary

Background

Rhinovirus infections cause exacerbations of asthma. We postulated that people with asthma are more susceptible to rhinovirus infection than people without the disease and compared the susceptibility of these groups.

Methods

We recruited 76 cohabiting couples. One person in every couple had atopic asthma and one was healthy. Participants completed daily diary cards of upper-respiratory-tract (URT) and lower-respiratory-tract (LRT) symptoms and measured peak expiratory flow twice daily. Every 2 weeks nasal aspirates were taken and examined for rhinovirus. Mixed models were used to compare risks of infection between groups. We also compared the severity and duration of infections.

Findings

We analysed 753 samples. Rhinovirus was detected in 10·1% (38/378) of samples from participants with asthma and 8·5% (32/375) of samples from healthy participants. After adjustment for confounding factors, asthma did not sinificantly increase risk of infection (odds ratio 1·15, 95% CI 0·71–1·87). Groups did not differ in frequency, severity, or duration of URT infections or symptoms associated with rhinovirus infection. First rhinovirus infection was associated more frequently with LRT infection in participants with asthma than in healthy individuals (12 of 28 infections vs four of 23, respectively, p=0·051). Symptoms of LRT associated with rhinovirus infection were sinificantly more severe (p=0·001) and longer-lasting in participants with asthma than in healthy participants (p=0·005).

Interpretation

People with atopic asthma are not at greater risk of rhinovirus infection than healthy individuals but suffer from more frequent LRT infections and have more severe and longer-lasting LRT symptoms.

Introduction

40–85% of asthma exacerbations are associated with upper-respiratory-tract (URT) virus infections,1, 2 of which 60% are caused by rhinoviruses. People with asthma might be more susceptible to rhinovirus infection than healthy individuals. The receptor for 90% of rhinoviruses, ICAM-1,3, 4 is upregulated in the lower airway epithelium of individuals with asthma,⁵ thus providing an explanation for increased susceptibility to rhinovirus infection in asthma.

Few studies have compared rates of rhinovirus infection in people with and without asthma. Horn and Gregg⁶ showed a trend towards more frequent rhinovirus infections in children at risk of developing asthma compared with controls, whereas other researchers have not noted any difference in rates of rhinovirus infection between people with asthma and healthy individuals.⁷ Research has been hampered by the insensitivity of conventional virological techniques and by studies in which analyses were done in people only when they had symptoms—and therefore did not control for reporting bias caused by severity of symptoms.

Detection of differences in the frequency, severity, or both of rhinovirus infections between people with asthma and healthy individuals would help in understanding the pathogenesis of asthma exacerbations induced by these infections and aid appropriate targeting of treatments. Techniques using reverse transcriptase polymerase chain reactions (RT-PCR)1, 8 have resulted in three-to-five fold increases in sensitivity of detection of rhinoviruses. To establish whether individuals with asthma are more susceptible to rhinovirus infection than healthy individuals we used RT-PCR in a 3-month longitudinal cohort study. We also compared the effects of rhinovirus infection on the duration and severity of symptoms between these two groups. Since previous findings have suggested that individuals with asthma have more symptoms than healthy people when infected with a URT virus,⁷ we took samples irrespective of whether symptoms were present to avoid reporting bias. We recruited cohabiting couples to ensure that exposure to virus infection was closely matched between the two groups.

Section snippets

Patients

We recruited people with asthma, aged 18–50 years, from family practitioners. The diagnosis of asthma was confirmed by use of a modified IUALDT questionnaire.⁹ We excluded current or previous smokers. Volunteers that fulfilled IUALDT criteria and who were living with partners who did not smoke or have asthma were skin tested for reactions to house dust mite, mixed grass pollen, and cat allergens.¹⁰ People with at least one response at least 3 mm larger than that induced by a control injection

Results

76 couples were enrolled in the study and made a total of 753 visits for nasal aspiration (378 by participants with asthma and 375 by healthy participants). The median age of both groups was 36 years (range 26–50 for people with asthma and 26–47 for healthy individuals). There were more men in the group with asthma than in the group without the disease (44 vs 32, p=0·05). 36 of the 76 participants with asthma reacted to one allergen, 27 to two, and 13 to all three.

51 participants developed one

Discussion

Our results suggest that individuals with asthma are not at increased risk of rhinovirus infection but have LRT clinical illness twice as frequently, more severe and long-lasting LRT symptoms, and greater falls in PEF when infected by rhinovirus than do healthy individuals. The effects of rhinovirus infection on the frequency of URT clinical illness and on the severity and duration of all symptoms associated with infection were similar in individuals with and without asthma.

We recruited

References (14)

JM Greve et al.
The major human rhinovirus receptor is ICAM 1
Cell
(1989)
KG Nicholson et al.
Respiratory viruses and exacerbations of asthma in adults
BMJ
(1993)
SL Johnston et al.
Community study of the role of viral infections in exacerbations of asthma in 9–11 year old children
BMJ
(1995)
TA Springer
Adhesion receptors of the immune system
Nature
(1990)
ND Manolitsas et al.
The expression of intercellular adhesion molecule-1 and the βl-integrins in asthma
Eur Respir J
(1994)
MEC Horn et al.
Role of viral infection and host factors in acute episodes of asthma and chronic bronchitis
Chest
(1973)
PK Pattemore et al.
Viruses as precipitants of asthma symptoms: I epidemiology
Clin Exp Allergy
(1992)

There are more references available in the full text version of this article.

Cited by (501)

Early-immune development in asthma: A review of the literature
2023, Cellular Immunology
This review presents a comprehensive examination of the various factors contributing to the immunopathogenesis of asthma from the prenatal to preschool period. We focus on the contributions of genetic and environmental components as well as the role of the nasal and gut microbiome on immune development. Predisposing genetic factors, including inherited genes associated with increased susceptibility to asthma, are discussed alongside environmental factors such as respiratory viruses and pollutant exposure, which can trigger or exacerbate asthma symptoms. Furthermore, the intricate interplay between the nasal and gut microbiome and the immune system is explored, emphasizing their influence on allergic immune development and response to environmental stimuli. This body of literature underscores the necessity of a comprehensive approach to comprehend and manage asthma, as it emphasizes the interactions of multiple factors in immune development and disease progression.
Asthma and COPD: distinct diseases or components of a continuum?
2023, Asthma in the 21st Century: New Research Advances
Asthma and COPD are two chronic bronchial diseases sharing several features including airways obstruction, inflammation, and clinical manifestations. However, they are also characterized by specific features in terms of determinants, natural history, physiological and imaging characteristics. Although their pharmacological treatment relies mostly on the same inhaled drugs, the strategy guiding their use is different, especially with respect to the position of inhaled corticosteroids. While these agents are the cornerstone of asthma management, they are indicated in COPD patients who share features with asthma, that is, eosinophilic inflammation. Whether asthma and COPD should be considered distinct disorders or as components of a continuum, is a matter of debate. Further research is needed before we can firmly choose between these hypotheses. Meanwhile, it remains crucial for both clinical practice and research to follow a rigorous diagnostic approach to properly characterize patients in terms of disease labeling, endotype, phenotype, and treatable traits.
Characteristics and outcomes of ambulatory patients with suspected COVID-19 at a respiratory referral center
2022, Respiratory Medicine
SARS-CoV-2 continues to cause a global pandemic and management of COVID-19 in outpatient settings remains challenging. Objective: We sought to describe characteristics of patients with chronic respiratory disease (CRD) experiencing symptoms consistent with COVID-19, who were seen in a novel Acute Respiratory Clinic, prior to widely available testing, emergence of variants, COVID-19 vaccination, and post-vaccination (breakthrough) SARS-CoV-2 infections. Methods: Retrospective electronic medical record data were analyzed from 907 adults with presumed COVID-19 seen between March 16, 2020 and January 7, 2021. Data included demographics, comorbidities, medications, vital signs, laboratory tests, pulmonary function tests, patient disposition, and co-infections. The overdispersed data (aod) R package was used to create a logit model using COVID-19 diagnosis by PCR as the dichotomous outcome variable. Univariate, conventional multivariate and elastic net machine learning were used to analyze data. Results: Male gender, elevated baseline temperature, and respiratory rate predicted COVID-19 diagnosis. Eosinopenia, neutrophilia, and lymphocytosis were also associated with COVID-19 diagnosis. However, asthma and COPD diagnoses were not associated with SARS-CoV-2 PCR positive test. Male gender, low oxygen saturation, and lower forced expiratory volume in 1 s (FEV₁) were associated with higher hospital referral. Conclusions: CRD patients with acute respiratory symptoms in the ambulatory setting were more likely to have COVID-19 if male, febrile and tachypneic. Patients with lower pre-morbid FEV₁ and lower SPO₂ are more likely to be referred to the hospital. A composite of vitals sigs and WBC differential help risk stratify CRD patients seeking care for presumed COVID-19.
Rhinovirus C replication is associated with the endoplasmic reticulum and triggers cytopathic effects in an in vitro model of human airway epithelium
2022, PLoS Pathogens
The clinical impact of rhinovirus C (RV-C) is well-documented; yet, the viral life cycle remains poorly defined. Thus, we characterized RV-C15 replication at the single-cell level and its impact on the human airway epithelium (HAE) using a physiologically-relevant in vitro model. RV-C15 replication was restricted to ciliated cells where viral RNA levels peaked at 12 hours post-infection (hpi), correlating with elevated titers in the apical compartment at 24hpi. Notably, infection was associated with a loss of polarized expression of the RV-C receptor, cadherin-related family member 3. Visualization of double-stranded RNA (dsRNA) during RV-C15 replication revealed two distinct replication complex arrangements within the cell, likely corresponding to different time points in infection. To further define RV-C15 replication sites, we analyzed the expression and colocalization of giantin, phosphatidylinositol-4-phosphate, and calnexin with dsRNA. Despite observing Golgi fragmentation by immunofluorescence during RV-C15 infection as previously reported for other RVs, a high ratio of calnexin-dsRNA colocalization implicated the endoplasmic reticulum as the primary site for RV-C15 replication in HAE. RV-C15 infection was also associated with elevated stimulator of interferon genes (STING) expression and the induction of incomplete autophagy, a mechanism used by other RVs to facilitate non-lytic release of progeny virions. Notably, genetic depletion of STING in HAE attenuated RV-C15 and -A16 (but not -B14) replication, corroborating a previously proposed proviral role for STING in some RV infections. Finally, RV-C15 infection resulted in a temporary loss in epithelial barrier integrity and the translocation of tight junction proteins while a reduction in mucociliary clearance indicated cytopathic effects on epithelial function. Together, our findings identify both shared and unique features of RV-C replication compared to related rhinoviruses and define the impact of RV-C on both epithelial cell organization and tissue functionality–aspects of infection that may contribute to pathogenesis in vivo.
A systematic two-sample and bidirectional MR process highlights a unidirectional genetic causal effect of allergic diseases on COVID-19 infection/severity
2024, Journal of Translational Medicine
Human Rhinovirus: Molecular and Clinical Overview
2024, Pharmacy Practice

View all citing articles on Scopus

View full text

ArticlesFrequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study

Summary

Background

Methods

Findings

Interpretation

Introduction

Section snippets

Patients

Results

Discussion

Cell

Respiratory viruses and exacerbations of asthma in adults

BMJ

Community study of the role of viral infections in exacerbations of asthma in 9–11 year old children

BMJ

Adhesion receptors of the immune system

Nature

The expression of intercellular adhesion molecule-1 and the βl-integrins in asthma

Eur Respir J

Role of viral infection and host factors in acute episodes of asthma and chronic bronchitis

Chest

Viruses as precipitants of asthma symptoms: I epidemiology

Clin Exp Allergy

Articles
Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study